Trials from the 2016 ESC Congress, including DANISH, NORSTENT, PRAGUE-18, ENSURE-AF, ANNEXA-4, LDL/low-BP exposure, and CE-MARC 2 are discussed by Dr John Mandrola in this week's podcast.